Abdelrahman Kobtan

Abdelrahman Kobtan

Auto-generated profile, based on publicly available information

Abdelrahman Kobtan

Department of Tropical Medicine and Infectious Diseases, Faculty of Medicine, Tanta University, Tanta, Egypt

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
ESElshazly Sheta
Elshazly Sheta
FEFerial El-Kalla
Ferial El-Kalla
MEMohamed El-Gharib
Mohamed El-Gharib
AKAbdelrahman Kobtan
Abdelrahman Kobtan
MEMohammed Elhendawy
Mohammed Elhendawy
IAIbrahim Amer
Ibrahim Amer
Background: Globally, hepatocellular carcinoma (HCC) is the third most frequent cause of cancer-related mortality. In recent years, transarterial chemoembolization, radiofrequency ablation, and microwave ablation (MWA) have been accepted as treatment modalities for patients with surgically unresectable HCC. Aim of this work: This study aimed to compare combination treatment with radiofrequency or MWA, followed by transarterial chemoembolization, and performed in a single session. Patients and methods: This study was carried out on 50 patients with nonresectable single-lesion HCC, who were divided into three groups: group A included 20 patients treated by transcatheter hepatic arterial chemoembolization, group B included 20 patients treated by radiofrequency thermal ablation combined with transcatheter arterial chemoembolization, and group C included 10 patients treated by MWA combined with transcatheter arterial chemoembolization. The combined treatments were performed in a single session, with the ablation performed first. Results: The total success rate in this study at 6 months following the procedure was 50% in group A, 70% in group B, and 80% in group C. Major complications were recorded in 22% of patients. The number of complications was the highest in group A. Conclusion: Combined ablation with chemoembolization is superior in the treatment of nonresectable single masses larger than 4 cm. Transcatheter arterial chemoembolization and ablation can be performed safely and successfully during a single session, which has not been found to decrease the response rates to treatment. Combined treatment with MWA is more effective in terms of tumor response, and results in the same complication rate as with radiofrequency, but less than chemoembolization alone.

28 November 2017 in Immunological Investigations
Verified
Journal Article
Closed access
NENadia Elwan
Nadia Elwan
Mohamed Labib SalemMohamed Labib Salem
Mohamed Labib Salem
AKAbdelrahman Kobtan
Abdelrahman Kobtan
FEFerial El-Kalla
Ferial El-Kalla
LMLoai Mansour
Loai Mansour
SASherief Abd-Elsalam
Sherief Abd-Elsalam
Background: Hepatocellular carcinoma (HCC) is the 3rd most common cause of cancer-related death worldwide. It has evolved different immune escape mechanisms, which might include emergence of lymphoid and myeloid regulatory cells. Aim of this work: To determine the numbers of Myeloid-derived suppressor cells (MDSCs) in peripheral blood and ascitic fluid in cirrhosis and HCC and their relation to IFN-γ and α-fetoprotein (α-FP). Patients and methods: Sixty individuals were enrolled in this study; forty cirrhotic patients with ascites; twenty without HCC (Group I), and twenty with HCC (group II) as well as twenty healthy individuals as a control group (group III). The phenotype and numbers of MDSCs were analyzed in peripheral blood of all the individuals and ascitic fluid of the patients using flow cytometry. Intracellular IFN-γ and serum alfa-fetoprotein were measured. Results: Significant increases in the relative and the mean number of peripheral blood MDSCs were found in the cirrhosis and HCC groups than in the control group, with the HCC group showing the highest number. MDSC count was negatively correlated with IFN-γ levels, while α-FP was positively correlated with MDSC% in the HCC group. MDSC count was low in ascitic fluid of both HCC and cirrhosis groups with no significant difference between the 2 groups. Conclusion: A high frequency of MDSCs was detected in the peripheral blood of cirrhotic and HCC patients, indicating presence of immunosuppressive arms. These cells could be targeted to develop a new effective immunotherapy or an adjuvant to current therapies.

1 August 2017 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
LMLoai Mansour
Loai Mansour
FEFerial El-Kalla
Ferial El-Kalla
HEHanan El-Bassat
Hanan El-Bassat
SASherief Abd-Elsalam
Sherief Abd-Elsalam
MEMohamed El-Bedewy
Mohamed El-Bedewy
MEMohamed Elhendawy
Mohamed Elhendawy

1 June 2016 in Medicine
Verified
Journal Article
Open access
SASherief Abd-Elsalam
Sherief Abd-Elsalam
EHEslam Habba
Eslam Habba
WEWalaa Elkhalawany
Walaa Elkhalawany
STSalwa Tawfeek
Salwa Tawfeek
HEHassan Elbatea
Hassan Elbatea
FRFatma Rizk
Fatma Rizk
Screening endoscopy is recommended for early detection of esophageal varices (EVs) in cirrhotic patients with portal hypertension. However, this approach is limited by its invasiveness and cost. The aim of the study was to determine if platelet count can predict the presence of EVs, especially large (grade III, IV) EVs in need of prophylactic therapy, in a cohort of Egyptian patients with liver cirrhosis. In all, 110 patients with cirrhosis were prospectively analyzed. The presence of medium or large EVs was correlated with patients' platelet count and FIB-4. Esophageal varices were present in 87 (79.09%) patients. Among those with thrombocytopenia (platelet level below 150,000), 25.97% (20 patients) and 27.27% (21 patients) had EV grade II and EV grade III or IV, respectively. Whereas in patients in whom the platelet count was above 150,000, only 21.21% (7 patients) and 9.09% (3 patients) of patients had grade II EV and EV grade III or IV, respectively. A platelet count cut-off value of 149,000 was found to have specificity of 82% and sensitivity 39% for detection of presence of varices. A FIB-4 cut-off value of 3.175 was found to have an 83.3% sensitivity and 39.5% specificity in detecting large (grade III, IV) EVs. Platelet count is a noninvasive parameter with high accuracy for prediction of EVs. Cirrhotic patients with normal platelet counts (above 150,000), especially in financially deprived developing countries, can avoid screening endoscopy as they are at a low risk for variceal bleeding, and presence of large EVs in these patients is much less common than in those with thrombocytopenia. A 3.175 cut-off value of FIB-4 could be useful as a noninvasive predictor of large varices requiring prophylactic banding in cirrhotic patients.

1 June 2016 in Medicine
Verified
Journal Article
Open access
SASherief Abd-Elsalam
Sherief Abd-Elsalam
AKAbdelrahman Kobtan
Abdelrahman Kobtan
FEFerial El-Kalla
Ferial El-Kalla
WEWalaa Elkhalawany
Walaa Elkhalawany
SNSally El Nawasany
Sally El Nawasany
MSMona Ah Shehata
Mona Ah Shehata
As there are increasing reports of fluoroquinolone resistance on use as a first- or second-line treatment for Helicobacter pylori (H pylori), we aimed at evaluation of the efficacy and safety of nitazoxanide-based regimen as a rescue regimen in Egyptian patients whose previous traditional treatment for H pylori infection failed.In total, 100 patients from the outpatient clinic of the Tropical medicine department, Tanta University hospital in whom the standard triple therapy (clarithromycin-based triple therapy) failed were enrolled in the study. Nitazoxanide (500 mg bid), levofloxacin (500 mg once daily), omeprazole (40 mg bid), and doxycyclin (100 mg twice daily) were prescribed for 14 days. Eradication was confirmed by stool antigen for H pylori 6 weeks after the end of treatment. Among the patients enrolled in the study, 44% of patients were men and the mean age for the participants in the study was 46.41 ± 8.05, 13% of patients were smokers, and 4% of patients had a previous history of upper gastro-intestinal bleeding. A total of 94 patients (94%) completed the study with excellent compliance. Only 1 patient (1%) discontinued treatment due to intolerable side effects and 5 patients (5%) did not achieve good compliance or were lost during follow up. However, 83 patients had successful eradication of H pylori with total eradication rates 83% (95 % CI 75.7–90.3%) and 88.30% (95 % CI 81.8–94.8%) according to an intention-to-treat and per-protocol analysis, respectively. Adverse events were reported in 21% of patients: abdominal pain (6%), nausea (9%) and constipation (12%), (2%) headache, and (1%) dizziness. A 2-week nitazoxanide-based regimen is an effective and safe rescue therapy in Egyptian patients whose previous standard triple therapy has failed.

6 December 2017 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
GAGhada Abdelmoemen
Ghada Abdelmoemen
SKSamy Abdelkader Khodeir
Samy Abdelkader Khodeir
SSSabry Abou- Saif
Sabry Abou- Saif
AKAbdelrahman Kobtan
Abdelrahman Kobtan
SASherief Abd-Elsalam
Sherief Abd-Elsalam